Vancouver Television · International

White House withdraws FDA nominee Dr. Heidi Overton amid signs she lacks enough Senate votes

White House withdraws FDA nominee Dr. Heidi Overton amid signs she lacks enough Senate votes

The White House has withdrawn Dr. Heidi Overton’s nomination to lead the U.S. Food and Drug Administration after Senate Republicans indicated she did not have the votes needed for confirmation.

The Story

The White House said Tuesday it has pulled the nomination of Dr. Heidi Overton to lead the Food and Drug Administration as it became increasingly clear she would not have the votes required to win U.S. Senate confirmation.

Overton, a physician and a White House domestic policy adviser, was nominated in August. The nomination was viewed by some as a move to bring a Trump loyalist to the FDA after a tumultuous year under Trump’s first FDA commissioner, Dr. Marty Makary.

In the Senate, Overton faced bipartisan questions, including concerns about whether she would be willing to break from President Donald Trump and Health Secretary Robert F. Kennedy Jr., a longtime vaccine critic. Republican Sen. Bill Cassidy, who chairs the Senate health committee, said earlier Tuesday that he was undecided ahead of a critical vote on her nomination scheduled for Wednesday morning.

Cassidy had previously said Overton’s support for Trump’s plan to break up combination vaccines, including the measles, mumps and rubella shot, was “almost disqualifying.” He also pressed her in a September hearing about her scientific independence and her willingness to disagree with Trump and Kennedy.

Late Tuesday night, Cassidy said in a posting on X that he believed Overton would have had the votes to pass out of committee and win a full Senate vote. He said the nomination was derailed by disagreements over abortion, adding that anti-abortion Republicans had sought commitments on “life issues” from the White House and that “the Administration withdrew Dr. Overton rather than make such commitments.”

Cassidy said earlier that a path forward would have required support from all 12 Republicans on the Senate Health, Education, Labor and Pensions Committee, where Democrats hold 11 seats. Without support of the committee, Overton faced little chance of winning a full Senate vote on the chamber floor.

While the nomination was withdrawn, the FDA is conducting a safety review of the abortion pill mifepristone at Trump’s request. The review could reinstate restrictions on the drug’s use, including a requirement for in-person prescribing, and the FDA has promised a report on its safety findings by March.

The FDA is currently being led on an acting basis by Kyle Diamantas, an attorney and friend of Donald Trump Jr., who was elevated to the post in May after serving as the agency’s top food official. Under federal rules, acting officials are limited to about seven months leading a federal agency.

← More stories